Association between β-blocker therapy and outcomes in patients hospitalised with acute exacerbations of chronic obstructive lung disease with underlying ischaemic heart disease, heart failure or hypertension

BACKGROUND: β-Blocker therapy has been shown to improve survival among patients with ischaemic heart disease (IHD) and congestive heart failure (CHF) and is underused among patients with chronic obstructive pulmonary disease (COPD). Evidence regarding the optimal use of β-blocker therapy during an a...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Thorax
Main Authors: Stefan, Mihaela S, Rothberg, Michael B, Priya, Aruna, Pekow, Penelope S, Au, David H, Lindenauer, Peter K
Formato: Artigo
Idioma:Inglês
Publicado: 2012
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4454610/
https://ncbi.nlm.nih.gov/pubmed/22941975
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/thoraxjnl-2012-201945
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares